<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04620564</url>
  </required_header>
  <id_info>
    <org_study_id>DKH-70113544</org_study_id>
    <nct_id>NCT04620564</nct_id>
  </id_info>
  <brief_title>Longitudinal Analysis of Mental Disorders, Psychosocial Distress and Care Needs of Patients and Their Relatives</brief_title>
  <acronym>LUPE</acronym>
  <official_title>Longitudinal Analysis of Mental Disorders, Psychosocial Distress and Psycho-oncological Care Needs of Patients and Their Relatives Stratified by Biopsychosocial Factors (LUPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Cancer Aid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives of this prospective observational multicenter study LUPE are to assess&#xD;
      the prevalence of mental disorders according to the DSM-5 (objective need for&#xD;
      psycho-oncological support), psychosocial distress, psycho-oncological care needs and&#xD;
      utilization of psycho-oncological support services (subjective need for support) of cancer&#xD;
      patients and their relatives during the first months of cancer survivorship stratified by&#xD;
      biopsychosocial factors including socioeconomic status. The investigators further aim to&#xD;
      identify moderating and mediating as well as associated factors for psychological distress&#xD;
      and supportive care needs.&#xD;
&#xD;
      LUPE will include 2000 adult patients with solid tumor entities and one relative per patient&#xD;
      at 4 measurement points from time of diagnosis to follow-up (+18 months) (t1: after&#xD;
      diagnosis, t2: 6 month later, t3: 6 month later, t4: 6 month later).&#xD;
&#xD;
      The investigators aim to generate a quota sample according to socioeconomic status (SES) that&#xD;
      is representative of the German overall population.&#xD;
&#xD;
      All participants will receive validated self-report questionnaires. Cancer patients will be&#xD;
      interviewed using the standardized clinical interview SCID-5.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of mental disorders according to the DSM-5 (objective need for psycho-oncological support) in cancer patients and the changes over time</measure>
    <time_frame>after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)</time_frame>
    <description>SCID (Structured Clinical Interview)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency and extent of psychological distress (Depression) (subjective psycho-oncological support needs) in cancer patients and their relatives and the changes over time</measure>
    <time_frame>after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)</time_frame>
    <description>PHQ (Patient Health Questionnaire - Depression)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency and extent of psychological distress (Anxiety) (subjective psycho-oncological support needs) in cancer patients and their relatives and the changes over time</measure>
    <time_frame>after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)</time_frame>
    <description>GAD (Generalized Anxiety Disorder)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Use of psycho-oncological support services by patients and relatives and the changes over time</measure>
    <time_frame>after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Quality of Life and the changes over time</measure>
    <time_frame>after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)</time_frame>
    <description>EORTC (European Organisation for Research and Treatment of Cancer - Quality of life)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protective factors and stress-increasing risk factors within the dyad of relatives and the changes over time</measure>
    <time_frame>after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)</time_frame>
    <description>DCI (Dyadic Coping Inventar)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adherence of the patients</measure>
    <time_frame>at follow up (Month 6)</time_frame>
    <description>AAQ (Adherence Assessment Questionnaire)</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Neoplasm Malignant</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Relatives</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with solid oncological tumors diagnosed no more than 4-8 weeks ago and meeting the&#xD;
        inclusion criteria. The relatives of the patients do not have to meet any special inclusion&#xD;
        criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary diagnosis of malignant solid tumor&#xD;
&#xD;
          -  a maximum time period after diagnosis of 4-8 weeks&#xD;
&#xD;
          -  minimum age of 18 years&#xD;
&#xD;
          -  cognitive ability to consent to study participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  presence of hematological cancers&#xD;
&#xD;
          -  patients with cancer recurrence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anja Mehnert-Theuerkauf, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit√§tsklinikum Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anja Mehnert-Theuerkauf, Prof</last_name>
    <phone>0049 431 9718880</phone>
    <email>anja.mehnert@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jochen Ernst, Prof</last_name>
    <phone>0049 341 9715415</phone>
    <email>jochen.ernst@medizin.uni-leipzig.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Mehnert-Theuerkauf, Prof</last_name>
      <phone>0049 341 - 97188005</phone>
      <email>anja.mehnert@medizin.uni-leipzig.de</email>
    </contact>
    <contact_backup>
      <last_name>Jochen Ernst, Prof</last_name>
      <phone>0049 341 - 9715415</phone>
      <email>jochen.ernst@medizin.uni-leipzig.de</email>
    </contact_backup>
    <investigator>
      <last_name>Anja Mehnert-Theuerkauf, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanja Zimmermann, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ute Goerling, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Anja Mehnert</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>psycho-oncology</keyword>
  <keyword>psychological care</keyword>
  <keyword>utilization</keyword>
  <keyword>distress</keyword>
  <keyword>mental disorders</keyword>
  <keyword>neoplasm malignant</keyword>
  <keyword>cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

